| Financial Year |
March 31 2023 |
| Monetary Funds |
917,783,554.78 |
| Held-for-trading Financial Assets |
69,627,474.51 |
| Notes Receivable |
257,389,381.23 |
| Accounts Receivable |
738,966,015.04 |
| Advances to Suppliers |
54,579,418.85 |
| Other Receivables |
17,776,347.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
328,816,674.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
46,697,831.06 |
| Total Current Assets |
2,854,466,023.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
101,147,528.50 |
| Investment Properties |
-- |
| Fixed Assetes |
886,605,534.31 |
| Under-construction Projects |
23,548,014.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,282,450.21 |
| R&D expenses |
-- |
| Goodwill |
99,418,923.61 |
| Long-Term Deferred and Prepaid Expenses |
15,888,467.35 |
| Deferred Income Tax Assets |
85,465,399.57 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,587,347,045.54 |
| Total Assets |
4,441,813,069.33 |
| Short-Term Loans |
100,389,694.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
148,690,086.30 |
| Accounts Payable |
174,002,646.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,068,560.50 |
| Taxes Payable |
44,635,103.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,663,752.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,462,358.22 |
| Other Current Liabilities |
5,661,251.43 |
| Sub-Total of Current Liabilities |
638,376,112.77 |
| Long-term Loans |
250,355,958.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,313,787.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
348,965,733.37 |
| Total Liabilities |
987,341,846.14 |
| Paid-In Capital(Or Share Stock) |
227,247,078.00 |
| Capital Surplus |
1,264,631,161.98 |
| Surplus Reserve |
18,997,410.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,939,574,973.41 |
| Minority Stockholder's Interest |
7,188,278.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,447,282,944.71 |
| Owner's Equity（Stockholder's Equity） |
3,454,471,223.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,441,813,069.33 |
